NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001481

Registered date:05/11/2008

Open labelled multicenter randomized comparative trial of high-dose toremifene for non-steroidal aromatase inhibitor resistant breast cancer compared to exemestane

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studiedAdvanced/recurrent breast cancer
Date of first enrollment2008/11/01
Target sample size90
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)TOR: Toremifene (120mg) is orally administered once a day everyday. EXE: Exemestane (25mg) is orally administered once a day everyday.

Outcome(s)

Primary Outcomeclinical benefit rate
Secondary Outcomeresponse rate, time to progression, time to treatment failure, adverse events, presictive factor

Key inclusion & exclusion criteria

Age minimum30years-old
Age maximumNot applicable
GenderFemale
Include criteria
Exclude criteria1. The case with active other malignancies 2. The case with past history of drug allergy or hypersensitivity 3. The case during pregnancy or lactation 4. The case with severe progressive situation with non-indication for the hormone therapy 5. The case judged inappropriate by physicians

Related Information

Contact

public contact
Name Ayako Okabe
Address 1-1-1 Honjo, Kumamoto Japan
Telephone 096-373-5521
E-mail bsokabe@kumamoto-u.ac.jp
Affiliation Graduate School of Medical Sciences Department of Breast and Endocrine Surgery
scientific contact
Name Hirotaka Iwase
Address 1-1-1 Honjo, Chuo-ku Kumamoto Japan
Telephone 096-373-5521
E-mail hiwase@kumamoto-u.ac.jp
Affiliation Graduate School of Medical Sciences, Kumamoto University Department of Breast and Endocrine Surgery